Pharmacopsychiatry 2015; 48(04/05): e2
DOI: 10.1055/s-0035-1555803
DOI: 10.1055/s-0035-1555803
Erratum
The Elimination Rate after Clozapine Overdose in Chinese Schizophrenia Patients: A Population Pharmacokinetics Model Study
Authors
-
A.-N. Li
1 Beijing Key Laboratory of Mental Disorders, Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China4 Center of Schizophrenia, Beijing Institute for Brain Disorders and Laboratory of Brain Disorders (Capital Medical University), Ministry of Science and Technology, Beijing, China -
F. Dong
1 Beijing Key Laboratory of Mental Disorders, Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China4 Center of Schizophrenia, Beijing Institute for Brain Disorders and Laboratory of Brain Disorders (Capital Medical University), Ministry of Science and Technology, Beijing, China -
J.-L. He
1 Beijing Key Laboratory of Mental Disorders, Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China4 Center of Schizophrenia, Beijing Institute for Brain Disorders and Laboratory of Brain Disorders (Capital Medical University), Ministry of Science and Technology, Beijing, China -
D.-W. Shang
2 Guangzhou Brain Hospital, Guangzhou Huiai Hospital, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China -
W. Guo
1 Beijing Key Laboratory of Mental Disorders, Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China4 Center of Schizophrenia, Beijing Institute for Brain Disorders and Laboratory of Brain Disorders (Capital Medical University), Ministry of Science and Technology, Beijing, China -
W.-B. Li
1 Beijing Key Laboratory of Mental Disorders, Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China4 Center of Schizophrenia, Beijing Institute for Brain Disorders and Laboratory of Brain Disorders (Capital Medical University), Ministry of Science and Technology, Beijing, China -
W. Lu
3 Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China -
C.-Y. Wang
1 Beijing Key Laboratory of Mental Disorders, Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China4 Center of Schizophrenia, Beijing Institute for Brain Disorders and Laboratory of Brain Disorders (Capital Medical University), Ministry of Science and Technology, Beijing, China